Close
SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

U.S. Patents Awarded to Inventors in New Jersey (Feb. 3)
[February 03, 2012]

U.S. Patents Awarded to Inventors in New Jersey (Feb. 3)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Feb. 3 -- The following federal patents were awarded to inventors in New Jersey.

*** Lockheed Martin Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Lockheed Martin, Bethesda, Md., has been assigned a patent (8,106,340) developed by Frederick U. Diaz, Philadelphia, and Jeffrey B. Boka, Lumberton, N.J., for a "generalized midcourse missile guidance." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for guiding a multistage interceptor missile toward a target missile that may transition from a boost mode to a ballistic mode during the engagement. The method comprises the steps of tracking the position of the target missile with a sensor, generating a predicted intercept point and time, and loading the predicted intercept point and time into the interceptor missile guidance system. The interceptor missile is launched and transition is made to the second stage of propulsion of the interceptor missile. Second-stage midcourse guidance acceleration commands are generated in response to an elevated predicted intercept point generated using the Runge-Kutta integration method working on predicted target missile position, velocity, and acceleration. During third stage propulsion said interceptor missile is guided toward an updated predicted intercept point of the target missile. During fourth stage, the kinetic warhead effects a hit-to-kill intercept of the target missile." The patent application was filed on March 2, 2009 (12/395,830). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=81,06,340.PN.&OS=PN/81,06,340&RS=PN/81,06,340 Written by Ruby Maibam; edited by Jaya Anand.

*** Cibus Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Cibus, San Diego, has been assigned a patent (8,106,259) developed by Peter R. Beetham, Carlsbad, Calif., Keith A. Walker, San Diego, and Patricia L. Avissar, New Brunswick, N.J., for "compositions and methods for plant genetic modification." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Mixed duplex oligonucleotides (MDON) are used to effect site-specific genetic alterations in a target DNA sequence of a plant. The MDON are introduced by electroporation into microspores. Thereafter, plants having a desired genetic alteration are produced by germinating the microspores." The patent application was filed on May 11, 2009 (12/463,891). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=81,06,259.PN.&OS=PN/81,06,259&RS=PN/81,06,259 Written by Ruby Maibam; edited by Jaya Anand.

*** Alcatel-Lucent USA Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Alcatel-Lucent USA, Murray Hill, N.J., has been assigned a patent (8,107,399) developed by Yigal Bejerano, Springfield, N.J., and Qunfeng Dong, Madison, Wis., for "methods and devices for providing robust nomadic wireless mesh networks using directional antennas." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The number of directional antennas and associated radios needed to ensure a nomadic wireless mesh network (NWMN) remains operational in the event of node or link failures, while minimizing delay and other unwanted effects, may be determined using novel methods and devices. Such a determination may reduce the number of antennas and radios a service or network provider normally uses, thus reducing its costs." The patent application was filed on June 8, 2007 (11/808,413). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,399&OS=8,107,399&RS=8,107,399 Written by Satyaban Rath; edited by Hemanta Panigrahi.


*** Avaya Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,107,401) developed by Ajita John, Holmdel, N.J., Reinhard P. Klemm , Basking Ridge, N.J., and Doree D. Seligmann, New York, for a "method and apparatus for providing a virtual assistant to a communication participant." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus are disclosed for providing a virtual assistant to at least one party of a communication. The virtual assistant is injected into the communication, for example, by a VXML engine. The operation of the virtual assistant is controlled by one or more software modules that are obtained from a proxy node. The software modules allow commands received from or destined for the party to be interpreted. The virtual assistant may optionally be customized based on a selection of the one or more supported external applications. The proxy node provides at least one method for the party that allows the party to access functionality provided by at least one external application. The proxy node interprets signals from the virtual assistant; converts the signals from the virtual assistant into commands for the external application; and converts one or more of commands, messages and data from the external application into signals understood by the virtual assistant." The patent application was filed on Nov. 15, 2004 (10/989,105). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,401&OS=8,107,401&RS=8,107,401 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Avaya Assigned Patent for Evaluating Quality of Service in an IP Network with Cooperating Relays ALEXANDRIA, Va., Feb. 3 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,107,385) developed by five co-inventors for "evaluating quality of service in an IP network with cooperating relays." The co-inventors are Bengi Karacali-Akyamac, Bridgewater, N.J., Mark John Karol, Fair Haven, N.J., Anjur Sundaresan Krishnakumar, Rocky Hill, N.J., Parameshwaran Krishnan, Basking Ridge, N.J., and Jean Meloche, Madison, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A technique is disclosed that evaluates a network path between (i) a first node in a first subnetwork of endpoint nodes, such as IP phones, and (ii) a second node in a second subnetwork. A "ricochet" node in the network path evaluates the path by probing one or both subnetworks, where the ricochet node acts as relay for traffic packets being transmitted between the two subnetworks. A given relay has only to probe a single, representative node within a subnetwork at any given time in order to obtain performance data that is representative of the subnetwork overall. By probing the representative node, the relay is able to acquire an assessment of network conditions that is valid for the path between the relay and any endpoint in the subnetwork. As a result, the disclosed technique reduces the probing overhead when many endpoint nodes on a given subnetwork are simultaneously active and experiencing adverse network conditions." The patent application was filed on Jan. 11, 2006 (11/329,933). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,385&OS=8,107,385&RS=8,107,385 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** InterDigital Technology Assigned Patent ALEXANDRIA, Va., Feb. 3 -- InterDigital Technology, Wilmington, Del., has been assigned a patent (8,107,393) developed by Kiran K. Vanganuru, King of Prussia, Pa., Gregory S. Sternberg, Mount Laurel, N.J., and William E. Lawton, Parker Ford, Pa., for a "method and apparatus for estimating a signal-to-interference ratio." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus for estimating a signal-to-interference ratio (SIR) are disclosed. A received signal includes signal energy on multiple basis functions. Desired signal energy in the received signal is transformed onto a first basis function with constant polarity. The desired signal energy is estimated by coherently averaging signal energy on the first basis function. A noise power is estimated by averaging signal energy on each basis function other than the first basis function and accumulating the averaged signal energy from the basis function other than the first basis function and scaling the accumulated signal energy to account for a noise estimate from the first basis function. An SIR is estimated by dividing the desired signal energy by the noise power." The patent application was filed on Feb. 26, 2009 (12/393,309). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,393&OS=8,107,393&RS=8,107,393 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Avaya Assigned Patentmfor Route Tracing Program Configured to Detect Particular Network Element Making Type of Service Modification ALEXANDRIA, Va., Feb. 3 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,107,388) developed by six co-inventors for a "route tracing program configured to detect particular network element making type of service modification." The co-inventors are Paul Blum, Highlands Ranch, Colo., Jean Meloche, Madison, N.J., Kenneth Pearl, Braintree, Mass., Anton Rager, Larkspur, Colo., Balaji Sathyanarayana Rao, Somerville, N.J., and John R. Tuck Jr., Berkeley Heights, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "One or more network elements that modify type of service values in a network are detected by sending route tracing messages having increasing time-to-live values and a designated type of service value from a first network element to a second network element. Type of service values are monitored in respective time exceeded messages received from respective network elements on a given network path between the first network element and the second network element responsive to the route tracing messages. At least a particular one of the network elements on the given network path that has made a modification in type of service value relative to the designated type of service value is identified, based on the monitored type of service values in the respective time exceeded messages." The patent application was filed on April 24, 2008 (12/108,949). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,388&OS=8,107,388&RS=8,107,388 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Telcordia Technologies Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Telcordia Technologies, Piscataway, N.J., has been assigned a patent (8,107,395) developed by Richard Lau, Morganville, N.J., HeeChang Kim, Marlboro, N.J., and Arnold L. Neidhardt, Middletown, N.J., for a "self-correcting adaptive tracking system (SATS)." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and method for self and group location and tracking based on ultra wide band ranging among members of the group is presented. The system comprises an anchored station, a plurality of nodes, each node having at least knowledge of where the node is facing and heading, knowledge of all pair wise distances among all of the plurality of nodes, and ability to exchange information among the nodes and with the anchored station via relays. The system and method find a new position estimate of the group in accordance with an adaptive search process based on constraints of the ultra wide band ranging, and the search process enables extracting directional information and adaptively stabilizing orientation of the group. In one embodiment, adaptively stabilizing the orientation of the group is performed using an orientation-correcting polygon matching process." The patent application was filed on June 26, 2009 (12/492,658). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,395&OS=8,107,395&RS=8,107,395 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** AT&T Intellectual Property I Assigned Patent ALEXANDRIA, Va., Feb. 3 -- AT&T Intellectual Property I, Atlanta, has been assigned a patent (8,107,381) developed by six co-inventors for "method of performing ethernet gateway switch trouble diagnostics." The co-inventors are Zhiqiang Qian, Holmdel, N.J., Paritosh Bajpay, Edison, N.J., Anamaria Csupor, Keyport, N.J., Jackson Liu, Middletown, N.J., Carlos Morales, Lakewood, N.J., and Michael Zinnikas, North Brunswick, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A service provider unit automatically diagnoses problems in an Ethernet network that are associated with layers 1, 2, and/or 3 and determines whether there is a problem associated with an Ethernet gateway switch EGS. Further diagnostics can be performed to determine the layer, type, and/or location of the problem(s) based on whether there is a problem with the EGS. The diagnostic process followed depends on the types of problem(s) in the network. Once the problems have been diagnosed, an operator can be notified of the location and/or type of problem." The patent application was filed on Nov. 27, 2007 (11/945,751). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,381&OS=8,107,381&RS=8,107,381 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Bristol-Myers Squibb Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,106,046) developed by Bingwei Vera Yang, Belle Mead, N.J., for "cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound of Formula (I) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are as defined herein. Also disclosed are pharmaceutical compositions and combinations containing compounds of Formula I and methods of treating diseases or disorders including metabolic and inflammatory or immune associated diseases or disorders. ##STR00001##." The patent application was filed on June 24, 2009 (12/996,806). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,046&OS=8,106,046&RS=8,106,046 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Avaya Assigned Patent for Simultaneous Active Registration in a SIP Survivable Network Configuration ALEXANDRIA, Va., Feb. 3 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,107,361) developed by seven co-inventors for a "simultaneous active registration in a SIP survivable network configuration." The co-inventors are Al Baker, Brick, N.J., Mehmet C. Balasaygun, Freehold, N.J., Frank J. Boyle, Denver, Gordon Brunson, Broomfield, Colo., Benjamin Jenkins, Zionsville, Ind., Pamela J. Lauber, Middletown, N.J., and Thomas A. Petsche, Neshanic Station, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are methods, devices, and systems for maintaining a SIP survivable network. The present invention is adapted to allow SIP endpoints or User Agents to discover and select the controller or controllers that the SIP endpoint will register with. Selection of the controller or controllers may be based upon the relative attributes of the controllers and the needs of the SIP endpoint." The patent application was filed on March 26, 2008 (12/056,246). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,361&OS=8,107,361&RS=8,107,361 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Johnson & Johnson Consumer Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Johnson & Johnson Consumer, Skillman, N.J., has been assigned a patent (8,106,094) developed by six co-inventors for "compositions and methods for treating skin conditions." The co-inventors are Archana Sah, Redmond, Wash., Victoria Dole, Whitehouse Station, N.J., Glenn Nystrand, Lebanon, N.J., Miri Seiberg, Princeton, N.J., Jue-Chen Liu, Belle Mead, N.J., and Ellen Kurtz, Ringoes, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to methods and compositions for treating and ameliorating skin conditions including post inflammatory hyperpigmentation (PIH). More particularly, this invention relates to compositions containing certain natural extracts, salicylic acid, and natural or synthetic retinoids. The composition was clinically proven to reduce PIH." The patent application was filed on July 30, 2004 (10/903,702). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,094&OS=8,106,094&RS=8,106,094 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,106,034) developed by Amjad Ali, Freehold, N.J., and Michael Man-Chu Lo, Edison, N.J., for "angiotensin II receptor antagonists." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound having the structure ##STR00001## wherein R is an angiotensin receptor blocking group Y is --(CR.sup.1R.sup.20).sub.1-7R.sup.5, or --C(O)(CR.sup.1R.sup.20).sub.1-7R.sup.5; R.sup.1 and R.sup.20 are independently selected from the group consisting of hydrogen or C.sub.1-4 alkyl; R.sup.5 is --O--N.dbd.N(O)--NR.sup.3R.sup.4; and R.sup.3 and R.sup.4 are independently selected from the group consisting of --CH.sub.2CH.sub.2OH, --CH.sub.2CH.sub.2OCH.sub.3, --C.sub.1-4 alkyl, unsubstituted or substituted C.sub.1-6 alkenyl, unsubstituted or substituted morpholino, amino, unsubstituted or substituted benzyl, unsubstituted or substituted phenyl, unsubstituted or substituted arylC.sub.1-4 alkyl, or R.sup.3 and R.sup.4 together with the nitrogen atom to which they are attached, form a ring selected from the group consisting of ##STR00002## or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of the stereoisomer thereof, which is useful for treating hypertension." The patent application was filed on Jan. 29, 2009 (12/864,448). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,034&OS=8,106,034&RS=8,106,034 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck Sharp & Dohme, Albany Molecular Research Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Merck Sharp & Dohme, Rahway, N.J., and Albany Molecular Research, Albany, N.Y., have been assigned a patent (8,106,070) developed by eight co-inventors for "substituted imidazoles as bombesin receptor subtype-3 modulators." The co-inventors are David Chen, Singapore, Christopher L. Franklin, Keasbey, N.J., Peter R. Guzzo, Niskayuna, N.Y., Linus S. Lin, Westfield, N.J., Jian Liu, Edison, N.J., Michael M.-C. Lo, Edison, N.J., Ravi P. Nargund, East Brunswick, N.J., and Iyassu K. Sebhat, Jersey City, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes." The patent application was filed on Oct. 16, 2007 (12/311,541). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,070&OS=8,106,070&RS=8,106,070 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Memory Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Memory Pharmaceuticals, Montvale, N.J., has been assigned a patent (8,106,066) developed by seven co-inventors for "indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof." The co-inventors are Richard Schumacher, Monroe, N.Y., Mihaela Diana Danca, Mendham, N.J., Jianguo Ma, Natick, Mass., Brian Herbert, Stockholm, N.J., True Minh Nguyen, New York, Wenge Xie, Mahwah, N.J., and Ashok Tehim, Ridgewood, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the .alpha.7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof." The patent application was filed on Sept. 22, 2006 (11/525,213). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,066&OS=8,106,066&RS=8,106,066 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** ExxonMobil Chemical Patents Assigned Patent ALEXANDRIA, Va., Feb. 3 -- ExxonMobil Chemical Patents, Houston, has been assigned a patent (8,106,248) developed by Paul F. Keusenkothen, Houston, and Frank Hershkowitz, Liberty Corner, N.J., for a "conversion of co-fed methane and hydrocarbon feedstocks into higher value hydrocarbons." The abstract of the patent published by the U.S. Patent and Trademark Office states: "In one aspect, the inventive process comprises a process for pyrolyzing a hydrocarbon feedstock containing nonvolatiles in a regenerative pyrolysis reactor system. The process comprises: (a) heating the nonvolatile-containing hydrocarbon feedstock upstream of a regenerative pyrolysis reactor system to a temperature sufficient to form a vapor phase that is essentially free of nonvolatiles and a liquid phase containing the nonvolatiles; (b) separating said vapor phase from said liquid phase; (c) feeding the separated vapor phase and methane to the pyrolysis reactor system; and (d) converting the methane and separated vapor phase in said pyrolysis reactor system to form a pyrolysis product. In another aspect, the invention includes a separation process that feeds multiple pyrolysis reactors." The patent application was filed on May 15, 2008 (12/121,353). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,248.PN.&OS=PN/8,106,248&RS=PN/8,106,248 Written by Shabnam Sheikh; edited by Jaya Anand.

*** ExxonMobil Chemical Patents Assigned Patent for Process for Producing Cyclohexylbenzene ALEXANDRIA, Va., Feb. 3 -- ExxonMobil Chemical Patents, Houston, has been assigned a patent (8,106,243) developed by five co-inventors for a "process for producing cyclohexylbenzene." The co-inventors are Tan-Jen Chen, Kingwood, Texas, Jane C. Cheng, Bridgewater, N.J., Francisco M. Benitez, Houston, Terry E. Helton, Bethlehem, Pa., and Jon E. Stanat, Westhampton Beach, N.Y.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "In a process for producing cyclohexylbenzene, benzene and hydrogen are contacted with a catalyst under hydroalkylation conditions to produce an effluent containing cyclohexylbenzene. The catalyst comprises a composite of a molecular sieve, an inorganic oxide different from said molecular sieve and at least one hydrogenation metal, wherein at least 50 wt % of said hydrogenation metal is supported on the inorganic oxide and the inorganic oxide has an average particle size less than 40 .mu.m (microns)." The patent application was filed on Feb. 23, 2009 (12/933,709). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,243.PN.&OS=PN/8,106,243&RS=PN/8,106,243 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Avaya Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,106,880) developed by Thomas Anthony Petsche, Neshanic Station, N.J., and Michael Vernick, Ocean, N.J., for a "sharing a video display between telephony and computing devices." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus and method are disclosed that enable the sharing, between a telephone and a computer, of input peripherals such as a keyboard and mouse and of output peripherals such as a video display. Historically, a telephone and a computer have possessed different interfaces with their user and with peripheral devices. Therefore, except where the telephone functionality is in the form of a softphone implemented on a computer, the telephone in the prior art is often incapable of sharing certain peripherals with a physically-adjacent computer. The telephone device of the illustrative embodiment enables sharing between the telephone and a computer, in contrast to sharing peripherals between computers in the prior art. The telephone device is able to determine which user inputs from a shared keyboard or mouse are intended for which data-processing device (i.e., the telephone device itself or the computer), and to transmit displayable signals from both the telephone device and computer to a shared video display device." The patent application was filed on March 27, 2007 (11/692,077). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,106,880&OS=8,106,880&RS=8,106,880 Written by Kusum Sangma; edited by Anand Kumar.

*** Vitae Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Vitae Pharmaceuticals, Fort Washington, Pa., has been assigned a patent (8,106,221) developed by fifteen co-inventors for renin inhibitors. The co-inventors are John J. Baldwin, Gwynedd Valley, Pa., Salvacion Cacatian, Blue Bell, Pa., David A. Claremon, Maple Glen, Pa., Lawrence W. Dillard, Yardley, Pa., Patrick T. Flaherty, Pittsburgh, Alexey V. Ishchenko, Somerville, Mass., Lanqi Jia, Horsham, Pa., Gerard McGeehan, Garnet Valley, Pa., Robert D. Simpson, Wilmington, Del., Suresh B. Singh, Kendall Park, N.J., Colin M. Tice, Ambler, Pa., Zhenrong Xu, Horsham, Pa., Jing Yuan, Lansdale, Pa., Wei Zhao, Eagleville, Pa., and Linghang Zhuang, Chalfont, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors." The patent application was filed on June 20, 2008 (12/665,219). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,221.PN.&OS=PN/8,106,221&RS=PN/8,106,221 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Eastman Chemical Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Eastman Chemical, Kingsport, Tenn., has been assigned a patent (8,106,111) developed by five co-inventors for an "antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions." The co-inventors are James Allen McCaulley, Ringoes, N.J., Terry Ann Oldfield, Kingsport, Tenn., Andrew Joseph Matosky, Kingsport, Tenn., Suzanne Winegar Dobbs, Kingsport, Tenn., and Vicky Lynn Christian, Mount Carmel, Tenn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A cycloaliphatic diol antimicrobial agent selected from the group consisting of 1,1-cyclohexanedimethanol, 1,2-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, and 2,2,4,4-tetramethyl-1,3-cyclobutanediol was found to provide antimicrobial activity in coating compositions and latexes, and was found to enhance the effectiveness of other antimicrobial agents commonly used in coatings and dispersions. Alone or as part of a preservative system, this cycloaliphatic diol antimicrobial agent in water can provide an easy-to-handle liquid that allows coatings producers to achieve improved microbial control, or achieve equivalent control while using less antimicrobial agents in their formulations. Consequently, the shelf life of the products can be maintained while reducing the use of the traditional preservative, or the shelf-life can be enhanced with addition of this cycloaliphatic diol antimicrobial agent to an existing antimicrobial system." The patent application was filed on May 13, 2010 (12/779,161). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,111.PN.&OS=PN/8,106,111&RS=PN/8,106,111 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Nova Photonics Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Nova Photonics, Princeton, N.J., has been assigned a patent (8,107,152) developed by Fred M. Levinton, Princeton, N.J., for an "electro-optical tunable birefringent filter." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An electrically tunable Lyot type filter is a Lyot that include one or more filter elements. Each filter element may have a planar, solid crystal comprised of a material that exhibits birefringence and is electro-optically active. Transparent electrodes may be coated on each face of the crystal. An input linear light polarizer may be located on one side of the crystal and oriented at 45 degrees to the optical axis of the birefringent crystal. An output linear light polarizer may be located on the other side of the crystal and oriented at -45 degrees with respect to the optical axis of the birefringent crystal. When an electric voltage is applied between the electrodes, the retardation of the crystal changes and so does the spectral transmission of the optical filter." The patent application was filed on Aug. 29, 2008 (12/201,614). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,107,152&OS=8,107,152&RS=8,107,152 Written by Kusum Sangma; edited by Anand Kumar.

*** Cellco Partnership Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Cellco Partnership, Basking Ridge, N.J., has been assigned a patent (8,106,819) developed by Iftekhar Rahman, Billerica, Mass., and Kala Narayanan, Edison, N.J., for an "optimizing performance of multiple location based service applications that are running either alone or simultaneously on a wireless device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Requests for location fix for a mobile device are received from one or more Location Based Service (LBS) applications. The received requests are queued in a First In First Out (FIFO) queue in the mobile device. Based on information in a first request out of the FIFO queue, the mobile device runs a location engine in a first fix mode to obtain a fix on the location of the mobile device for a response to the first request. While the location engine is running to obtain the fix for the response to the first request, the mobile device analyzes information in a second request in the FIFO queue, to determine a second fix mode for response to the second request. Based on a comparison of the second fix mode to the first fix mode, the mobile device may change the information in the second request to correspond to the first fix mode, before output of the second request from the FIFO queue to the location engine." The patent application was filed on Dec. 30, 2010 (12/982,462). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8106819.PN.&OS=PN/8106819&RS=PN/8106819 Written by Kusum Sangma; edited by Anand Kumar.

*** ARIAD Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 3 -- ARIAD Pharmaceuticals, Cambridge, Mass., has been assigned a patent (8,106,191) developed by five co-inventors for synthetic multimerizing agents. The co-inventors are Dennis A. Holt, Royersford, Pa., Terence P. Keenan, Cambridge, Mass., Tao Guo, Dayton, N.J., Edgardo Laborde, Forest City, Calif., and Wu Yang, Princeton, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M-L-Q where M is a synthetic ligand for an FKBP protein." The patent application was filed on June 13, 2003 (10/461,705). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,191.PN.&OS=PN/8,106,191&RS=PN/8,106,191 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Ortho-McNeil Pharmaceutical Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Ortho-McNeil Pharmaceutical, Raritan, N.J., has been assigned a patent (8,106,153) developed by six co-inventors for an "ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease." The co-inventors are Zeling Cai, San Diego, Michael R. Jackson, Del Mar, Calif., Per A. Peterson, Basking Ridge, N.J., Wei-Xing Shi, San Diego, Yan Kong, Belle Mead, N.J., and Juli DeGraw, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Cytotoxic T lymphocytes (CTLs) specific for antigenic peptides derived from IgE molecule can be generated in vitro by stimulating resting naive CD8 T cells with IgE peptides presented by artificial antigen presenting cells. The IgE specific CTLs lyse the target cells loaded with IgE peptides in vitro and inhibit antigen specific IgE response in vivo. In addition, adoptive transfer of the IgE specific CTL to an asthmatic mouse model can inhibit the development of lung inflammation and airway hypersensitivity. IgE specific CTL provides a treatment for allergic asthma and other IgE-mediated allergic diseases. Antigenic peptides identified from non-tumor self-antigens induce specific cytotoxic T lymphocyte (CTL) in vitro. The CTL induced by peptides identified from CD40L can kill activated CD4 T cells. In vitro generated CTL specific for CD40L inhibit CD4-dependent antibody responses of all isotypes in vivo. In contrast, CTL induced by antigenic peptides derived from IgE specifically inhibit IgE responses, and adoptive transfer of CD40L-specific CTL to NOD mice at early age delay the development of diabetes in NOD mice. In vitro generated CTL specific for non-tumor self-antigens expressed on activated CD4 T cells regulate immune responses in vivo." The patent application was filed on Sept. 28, 2010 (12/892,068). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,153.PN.&OS=PN/8,106,153&RS=PN/8,106,153 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Dow Global Technologies Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Dow Global Technologies, Midland, Mich., has been assigned a patent (8,106,139) developed by twelve co-inventors for "propylene/alpha-olefin block interpolymers." The co-inventors are Gary R. Marchand, Lake Jackson, Texas, Yunwa W. Cheung, Hillsborough, N.J., Benjamin C. Poon, Pearland, Texas, Jeffrey D. Weinhold, Lake Jackson, Texas, Kim L. Walton, Lake Jackson, Texas, Pankaj Gupta, Midland, Mich., Colin Li Pi Shan, Pearland, Texas, Phillip D. Hustad, Manvel, Texas, Roger L. Kuhlman, Lake Jackson, Texas, Edmund M. Carnahan, Fresno, Texas, Eddy I. Garcia-Meitin, Angleton, Texas, and Patricia L. Roberts, Pearland, Texas.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments of the invention provide a class of mesophase separated propylene/.alpha.-olefin block interpolymers with controlled block sequences. The propylene/.alpha.-olefin interpolymers are characterized by an average block index, ABI, which is greater than zero and up to about 1.0 and a molecular weight distribution, M.sub.w/M.sub.n, greater than about 1.4. Preferably, the block index is from about 0.2 to about 1. In addition or alternatively, the block propylene/.alpha.-olefin interpolymer is characterized by having at least one fraction obtained by Temperature Rising Elution Fractionation ("TREF"), wherein the fraction has a block index greater than about 0.3 and up to about 1.0 and the propylene/.alpha.-olefin interpolymer has a molecular weight distribution, M.sub.w/M.sub.n, greater than about 1.4." The patent application was filed on Jan. 30, 2009 (12/864,178). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,106,139.PN.&OS=PN/8,106,139&RS=PN/8,106,139 Written by Shabnam Sheikh; edited by Jaya Anand.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1074975 (c) 2012 Targeted News Service

[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.